- 专利标题： Heterocyclic compound
-
申请号： US15517227申请日： 2015-10-22
-
公开(公告)号： US10214498B2公开(公告)日： 2019-02-26
- 发明人: Yoshihiro Banno , Masahiro Kamaura , Kazuaki Takami , Koichiro Fukuda , Shigekazu Sasaki
- 申请人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 代理机构： Haug Partners LLP
- 代理商 Michael T. Rafa
- 优先权： JP2014-217770 20141024
- 国际申请： PCT/JP2015/079782 WO 20151022
- 国际公布： WO2016/063933 WO 20160428
- 主分类号： A61P27/02
- IPC分类号： A61P27/02 ; C07K14/47 ; C12N15/09 ; A61K31/415 ; A61K31/505 ; C07D213/65 ; C07D213/70 ; C07D231/12 ; C07D231/22 ; C07D239/34 ; A61K31/4418 ; A61K31/421 ; C07D263/38 ; C07D263/46
摘要：
Provided is a heterocyclic compound having a superior RBP4-lowering action and useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4. A compound represented by the formula (I): wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
公开/授权文献
- US20180237404A1 HETEROCYCLIC COMPOUND 公开/授权日：2018-08-23
信息查询
